| Title |
Author |
Type |
Date |
Words |
| Micell Technologies Receives CE Mark Approval for MiStent SES. |
|
|
Jun 12, 2013 |
1505 |
| Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market. |
|
|
Jun 7, 2013 |
525 |
| Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market. |
|
|
Jun 7, 2013 |
519 |
| Supply of medicines coronary stents for cardiology clinics - adult section. |
|
|
Jun 1, 2013 |
147 |
| External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008. |
Huesch, Marco D. |
|
Jun 1, 2013 |
8116 |
| Global Bioabsorbable Stents Market - Market Analysis and Forecasts. |
|
Industry overview |
May 30, 2013 |
1136 |
| Global Bioabsorbable Stents Market - Market Analysis and Forecasts. |
|
Industry overview |
May 30, 2013 |
1131 |
| Biosensors Reports Financial Results for Fiscal Year 2013. |
|
Financial report |
May 29, 2013 |
2178 |
| OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents. |
|
|
May 27, 2013 |
1131 |
| MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players. |
|
|
May 27, 2013 |
2817 |
| MediPoint: Peripheral Vascular Stents for the Lower Extremity - APAC Analysis and Market Forecasts. |
|
Company overview |
May 27, 2013 |
4297 |
| MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts. |
|
Company overview |
May 27, 2013 |
4294 |
| MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts. |
|
Company overview |
May 27, 2013 |
4145 |
| MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts. |
|
Company overview |
May 27, 2013 |
4448 |
| OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents. |
|
|
May 27, 2013 |
1144 |
| InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group. |
|
|
May 23, 2013 |
1482 |
| OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients. |
|
Clinical report |
May 22, 2013 |
903 |
| Boston Scientific Promus PREMIER(TM) And SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data. |
|
|
May 22, 2013 |
1456 |
| Boston Scientific Promus PREMIER(TM) And SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data. |
|
|
May 22, 2013 |
1462 |
| Delayed Healing of Coronary Artery Following Implantation of Drug Eluting Stents, Increasing Risk of Thrombosis, is a Top Concern of Interventional Cardiologists, International Survey Shows. |
|
|
May 21, 2013 |
422 |
| Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent. |
|
|
May 21, 2013 |
1326 |
| OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings. |
|
|
May 21, 2013 |
639 |
| Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent. |
|
|
May 21, 2013 |
1322 |
| Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A. |
|
Industry overview |
May 21, 2013 |
6073 |
| OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients. |
|
Clinical report |
May 20, 2013 |
876 |
| Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013. |
|
|
May 17, 2013 |
1981 |
| Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013. |
|
|
May 17, 2013 |
1987 |
| InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent (EPS) From Brazil's Largest Private Insurer. |
|
|
May 16, 2013 |
1075 |
| Cardiovascular devices . |
|
|
May 16, 2013 |
233 |
| InspireMD to Announce Six-Month Results from the MGuard(TM) Embolic Protection Stent (EPS) MASTER Trial at EuroPCR. |
|
Financial report |
May 16, 2013 |
1914 |
| Analysis of Coronary Stent in US. |
|
|
May 15, 2013 |
981 |
| Medical equipments . |
|
|
May 14, 2013 |
454 |
| University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients. |
|
|
May 14, 2013 |
1881 |
| COMBO Dual Therapy Stent(TM) Clinical Results to Be Featured at EuroPCR 2013. |
|
|
May 13, 2013 |
854 |
| G. B. Pant Hospital runs short of stents. |
|
|
May 12, 2013 |
295 |
| European Market for Interventional Cardiology Devices. |
|
Industry overview |
May 9, 2013 |
2239 |
| InspireMD Reports Financial Results For Period Ended March 31, 2013. |
|
|
May 8, 2013 |
5422 |
| Global Bioabsorbable Stents Industry. |
|
Industry overview |
May 8, 2013 |
1204 |
| Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, Size, S. |
|
|
May 8, 2013 |
2006 |
| Global Coronary Stents - Market Growth Analysis, 2009-2015. |
|
Industry overview |
May 7, 2013 |
3263 |
| Nephrology And Urology Devices Market (Dialysis Equipment, Lithotripsy, Urethral Stent & Inserts, Pessaries, Prostatic Stent, Pelvic Organ Prolapse, Benign Prostatic Hyperplasia) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018. |
|
Industry overview |
Apr 30, 2013 |
2250 |
| Angiography supplies . |
|
|
Apr 26, 2013 |
224 |
| Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017. |
|
|
Apr 25, 2013 |
3886 |
| Cardiovascular Summit TCTAP 2013 Symposium to Feature OrbusNeich's COMBO Dual Therapy Stent (TM). |
|
|
Apr 23, 2013 |
620 |
| Global Vascular Stents Market 2012-2016. |
|
Industry overview |
Apr 19, 2013 |
1019 |
| Data Published in JACC: Cardiovascular Interventions Show that OrbusNeich's COMBO Dual Therapy Stent(TM) Reaches Primary Study Endpoint and Is Effective in Controlling Neointimal Proliferation. |
|
|
Apr 17, 2013 |
1292 |
| supply of disposable equipment. |
|
|
Apr 17, 2013 |
381 |
| Data Published in JACC: Cardiovascular Interventions Show that OrbusNeich's COMBO Dual Therapy Stent(TM) Reaches Primary Study Endpoint and Is Effective in Controlling Neointimal Proliferation. |
|
|
Apr 16, 2013 |
1306 |
| Endoscopy, endosurgery devices. |
|
|
Apr 16, 2013 |
557 |
| Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, Cerebral Angioplasty Balloons] - Global Trends & Competitive Analysis - 2017. |
|
|
Apr 15, 2013 |
678 |
| Stenting dramatically improves treatment access for dialysis patients. |
|
|
Apr 15, 2013 |
1243 |
| Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, Cerebral Angioplasty Balloons] - Global Trends & Competitive Analysis - 2017. |
|
|
Apr 15, 2013 |
684 |
| Carolinas HealthCare System Performs First-In-Human Stent Graft Implantation. |
|
|
Apr 15, 2013 |
817 |
| Drug-coated stents prevent leg amputation. |
|
|
Apr 14, 2013 |
1085 |
| Stenting blocked bowel arteries saves lives. |
|
|
Apr 14, 2013 |
1129 |
| Cardiac catheter - stent - balloon catheter - vascular closure systems. |
|
|
Apr 13, 2013 |
113 |
| Provision of implantable medical devices: vascular prostheses, visceral, ocular, gastrointestinal stents, implantable chambers, various. |
|
|
Apr 3, 2013 |
170 |
| Transplant renal artery stenosis secondary to mechanical compression from polycystic kidney disease: A case report. |
Lee, Linda; Gunaratnam, Lakshman; Sener, Alp |
|
Apr 1, 2013 |
1960 |
| Cordis completes Flexible Stenting Solutions acquisition. |
|
|
Apr 1, 2013 |
460 |
| Angioplasty supplies . |
|
|
Mar 30, 2013 |
289 |
| Vascular prostheses . |
|
|
Mar 26, 2013 |
152 |
| 600th Heart Attack Patient Recruited into Phase III CicloMulsion CIRCUS Trial. |
|
|
Mar 22, 2013 |
1250 |
| 600th Heart Attack Patient Recruited into Phase III CicloMulsion CIRCUS Trial. |
|
|
Mar 22, 2013 |
1256 |
| Cardiovascular devices . |
|
|
Mar 21, 2013 |
283 |
| 'Treatment changed my sex life' Spire Healthcare outline how a pioneering new stent procedure is helping to treat erectile dysfunction. |
|
|
Mar 18, 2013 |
431 |
| InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent. |
|
|
Mar 15, 2013 |
1134 |
| The Zacks Analyst Blog Highlights: Boston Scientific, Abbott Laboratories, Cyberonics, Given Imaging and Aflac. |
|
|
Mar 14, 2013 |
1579 |
| Provision of Coronary endoprostheses. |
|
|
Mar 14, 2013 |
271 |
| Provision of Angioplasty supplies. |
|
|
Mar 14, 2013 |
496 |
| The Boston Scientific PROMUS Element(TM) Platinum Chromium Stent Demonstrates Continued Low Event Rates Through Three Years. |
|
|
Mar 10, 2013 |
1304 |
| Germany : Bayer Initiates Xarelto (Rivaroxaban) Study in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stent Placement. |
|
Clinical report |
Mar 9, 2013 |
363 |
| New 'disappearing stent' restores blood flow to hearts. |
|
|
Mar 4, 2013 |
735 |
| A hunger to serve: Romano feeds disadvantaged students and helped bring a pioneering heart stent to market. |
|
|
Mar 1, 2013 |
804 |
| Better polymeric stents. |
Corneliussen, Roger |
Brief article |
Mar 1, 2013 |
127 |
| Millions of Americans with Peripheral Artery Disease now have new treatment option with better results. |
|
|
Feb 28, 2013 |
485 |
| STENTYS to Present Final Results From 1,000 Heart Attack Patient Study at ACC.13. |
|
|
Feb 26, 2013 |
934 |
| New Research: 2013 Global and China Coronary Stent Market. |
|
|
Feb 23, 2013 |
270 |
| Research and Markets: MediPoint: Bioabsorbable Stents - EU Analysis and Market Forecasts. |
|
|
Feb 22, 2013 |
574 |
| Research and Markets: MediPoint: Bioabsorbable Stents - Current and Future Players. |
|
|
Feb 22, 2013 |
488 |
| Research and Markets: MediPoint: Bioabsorbable Stents - Global Analysis and Market Forecasts. |
|
Industry overview |
Feb 21, 2013 |
556 |
| Research and Markets: MediPoint: Bioabsorbable Stents - US Analysis and Market Forecast. |
|
Industry overview |
Feb 21, 2013 |
358 |
| Covidien Completes Patient Enrollment in Iliac Stent Clinical Study Series. |
|
Clinical report |
Feb 20, 2013 |
900 |
| Research and Markets: Drug-Eluting Stents - Global Business Strategic Report - 2012-2017. |
|
Report |
Feb 13, 2013 |
376 |
| Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval. |
|
|
Feb 12, 2013 |
1198 |
| Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval. |
|
|
Feb 12, 2013 |
1204 |
| US Bioabsorbable Stent Market Examined in New Topical GlobalData Report Available at MarketPublishers.com. |
|
|
Feb 7, 2013 |
379 |
| Biosensors Collaborates with Terumo to Promote Nobori(TM) in Japan. |
|
|
Feb 7, 2013 |
711 |
| Twelve-Month Outcomes of Popliteal Artery Treatment with the Supera Peripheral Stent System Published in JACC Cardiovascular Interventions. |
|
|
Feb 5, 2013 |
616 |
| Twelve-Month Outcomes of Popliteal Artery Treatment with the Supera Peripheral Stent System Published in JACC Cardiovascular Interventions. |
|
|
Feb 5, 2013 |
619 |
| European Intervention Cardiology Market to Show Flat Growth Through 2017. |
|
|
Jan 31, 2013 |
752 |
| Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study. |
|
Clinical report |
Jan 30, 2013 |
773 |
| Cardiovascular devices. |
|
|
Jan 29, 2013 |
263 |
| Biosensors Receives CE Mark Approval for BioFreedom(TM). |
|
|
Jan 28, 2013 |
812 |
| Transport framework agreement vascular prostheses and stents grafts transportation. |
|
|
Jan 28, 2013 |
239 |
| Bolton Medical Selects Expect Advertising, Inc. to Launch Their New Product, Relay[R] Thoracic Stent-Graft. |
|
|
Jan 25, 2013 |
296 |
| Cardiovascular devices. |
|
|
Jan 24, 2013 |
291 |
| Clinical Results for the Supera Peripheral Stent System Highlighted At Leading Global Peripheral Intervention Course. |
|
Clinical report |
Jan 24, 2013 |
761 |
| Clinical Results for the Supera Peripheral Stent System Highlighted At Leading Global Peripheral Intervention Course. |
|
Clinical report |
Jan 24, 2013 |
791 |
| Angiography supplies. |
|
|
Jan 23, 2013 |
252 |
| Bolton Medical selects Expect Advertising, Inc. to launch their new product, Relay Thoracic Stent-Graft. |
|
|
Jan 22, 2013 |
435 |
| Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers. |
|
|
Jan 22, 2013 |
3107 |
| Delivery stentgrafts for na homolce hospital. |
|
|
Jan 19, 2013 |
131 |
| Gore Unveils Q50[R] PLUS Stent Graft Balloon Catheter. |
|
|
Jan 17, 2013 |
612 |
| Sulaiman Al Habib Medical Center starts using smart stents. |
|
|
Jan 14, 2013 |
262 |
| 40 set hemodialysis catheter double-lumen latex free polyurethane, 12 fr x 20 cms. Long, containing: 1 guide "j" with brands, 2 stents vena (8fr 15cms x 10cms and 12frx), 1 introducer needle 18g x 7 c. |
|
|
Jan 10, 2013 |
173 |
| Tryton Medical Completes $24 Million Equity Financing with Strong Participation from All Current Investors. |
|
|
Jan 7, 2013 |
869 |
| Vascular prostheses. |
|
|
Jan 4, 2013 |
233 |
| Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System. |
|
|
Jan 3, 2013 |
1091 |
| Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System. |
|
|
Jan 3, 2013 |
1105 |
| STENTYS Clinical Study Demonstrating Superiority of Self-Apposing[R] Stents Over Conventional Stents Published in American College of Cardiology Journal. |
|
Clinical report |
Jan 3, 2013 |
1015 |
| Dr. Farzan Filsoufi Advises New Heart Study Shows Diabetic Patients with Multiple Blockages Live Longer with Bypass Surgery than Stents. |
|
|
Jan 2, 2013 |
564 |
| Endovascular treatment of stent fracture and pseudoaneurysm formation in arteriovenous fistula dialysis access. |
Kershen, L. Michael; Marichal, Daniel A. |
Case study |
Jan 1, 2013 |
1286 |
| Medtronic kicks off the New Year with major clinical studies: U.S. enrollment in drug-eluting balloon trial completed. |
|
Clinical report |
Jan 1, 2013 |
1619 |
| FDA approves Abbott drug eluting stent system. |
|
|
Jan 1, 2013 |
461 |
| Stent upstaged after twins steal limelight. |
|
|
Dec 24, 2012 |
240 |
| FSS Introduces Ground Breaking Stent Delivery Technology with the CE Marking of its Reconstrainable FlexStent[R] Femoropopliteal SE Stent System. |
|
|
Dec 21, 2012 |
421 |
| Svelte Medical Systems Announces Treatment of First Patient in the ACES Effectiveness Study. |
|
Clinical report |
Dec 20, 2012 |
615 |
| Abbott rolls out unique stent in Indian mkt. |
|
|
Dec 20, 2012 |
301 |
| First U.S. Patient Treated Following FDA Approval of Cook Medical's First-of-Its-Kind Zilver[R] PTX[R] Drug-Eluting Peripheral Stent. |
|
|
Dec 19, 2012 |
972 |
| St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization. |
|
Clinical report |
Dec 18, 2012 |
1208 |
| InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting. |
|
|
Dec 4, 2012 |
1122 |
| First Patient Enrolled in Boston Scientific Randomized Study of Removable WallFlex Biliary RX Fully Covered Stent for Patients Suffering From Chronic Pancreatitis. |
|
Clinical report |
Dec 4, 2012 |
1215 |
| The Christ Hospital On Cutting Edge Of New Stent Technology; Implants Investigational New Device. |
|
|
Dec 3, 2012 |
606 |
| Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. |
Kuyumcuoglu, Ugur; Eryildirim, Bilal; Tuncer, Murat; Faydaci, Gokhan; Tarhan, Fatih; Ozgül, |
Report |
Dec 1, 2012 |
2594 |
| First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY(TM) Coronary Stent System Featuring a Bioabsorbable Polymer Coating. |
|
|
Nov 30, 2012 |
1100 |
| Tryton Medical Announces Completion of Patient Enrollment in Landmark Pivotal Study of Side Branch Stent. |
|
Clinical report |
Nov 26, 2012 |
924 |
| Research and Markets: International Physician Survey: Stents by Brand, Length, Diameter, Type and Coating - Executive Summary. |
|
|
Nov 23, 2012 |
292 |
| INCRAFT[TM] AAA Stent-Graft System One-Year Follow-Up Data Presented at 2012 Veith Symposium. |
|
|
Nov 19, 2012 |
1020 |
| Angiotech partner Cook Medical receives FDA approval for its Zilver PTX Paclitaxel-eluting peripheral stent. |
|
|
Nov 16, 2012 |
1156 |
| Cook Medical's Zilver[R] PTX[R] Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease. |
|
|
Nov 15, 2012 |
1805 |
| CABG bests multivessel stenting in diabetes. |
Jancin, Bruce |
|
Nov 15, 2012 |
890 |
| Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents. |
|
Clinical report |
Nov 14, 2012 |
1080 |
| S.M.A.R.T.[R] Vascular Stent Systems Receive FDA Approval for Use in SFA. |
|
|
Nov 8, 2012 |
627 |
| Positive Results of InspireMD's MASTER Trial to be Published on November 6 in Journal of American College of Cardiology. |
|
|
Nov 5, 2012 |
1382 |
| Research and Markets: Global Drug-Eluting Stents Market 2011-2015: The Global Drug-Eluting Stents Market to Reach US$6,278 Million By 2015. |
|
|
Nov 2, 2012 |
440 |
| Boston Scientific Receives CE Mark Approval for the SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating. |
|
|
Oct 31, 2012 |
1761 |
| Boston Scientific Receives CE Mark Approval for the SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating. |
|
|
Oct 31, 2012 |
1666 |
| Research and Markets: Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers. |
|
|
Oct 30, 2012 |
576 |
| MAQUET Joins Stent For Life Initiative. |
|
|
Oct 29, 2012 |
659 |
| Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami. |
|
Conference news |
Oct 29, 2012 |
1048 |
| 8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012. |
|
|
Oct 25, 2012 |
845 |
| Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne[R] System. |
|
|
Oct 24, 2012 |
698 |
| PROMUS Element(TM) and PROMUS Element(TM) Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy. |
|
|
Oct 24, 2012 |
893 |
| PROMUS Element(TM) and PROMUS Element(TM) Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy. |
|
|
Oct 24, 2012 |
887 |
| The Boston Scientific Epic(TM) Stent Continues to Demonstrate Positive Clinical Outcomes for Patients with Iliac Artery Disease. |
|
|
Oct 23, 2012 |
1332 |
| The Boston Scientific PROMUS Element(TM) Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions. |
|
|
Oct 23, 2012 |
1048 |
| Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES. |
|
Clinical report |
Oct 23, 2012 |
1648 |
| Cappella Medical Announces Excellent Long Term Follow-Up Results for Its Sideguard[R] Technology at TCT 2012. |
|
Financial report |
Oct 22, 2012 |
634 |
| Svelte Medical Systems Announces FDA Approval to Initiate a Pivotal Study of Its Coronary Stent Integrated Delivery System (IDS). |
|
|
Oct 22, 2012 |
537 |
| STENTYS Self-Apposing[R] Stent Continues to Demonstrate Low Mortality at One Year in APPOSITION III Trial. |
|
Clinical report |
Oct 22, 2012 |
1122 |
| STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing[R] Stent. |
|
|
Oct 22, 2012 |
877 |
| IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA Stent. |
|
|
Oct 22, 2012 |
823 |
| Tryton Announces Clinical Presentations at TCT 2012 Conference in Miami. |
|
Conference news |
Oct 16, 2012 |
999 |
| Micell Technologies Announces Clinical Data Presentations at TCT 2012. |
|
Clinical report |
Oct 16, 2012 |
1214 |
| OrbusNeich's COMBO Dual Therapy Stent(TM) to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012. |
|
|
Oct 16, 2012 |
883 |
| STENTYS to Present One-Year Interim Results From APPOSITION III Study at TCT Conference. |
|
Conference news |
Oct 15, 2012 |
706 |
| Cordis Corporation Announces One-Year Results from the STROLL Trial. |
|
|
Oct 11, 2012 |
697 |
| Cook Medical's Zilver[R] PTX[R] Trial Shows Sustained Patency after Three Years. |
|
|
Oct 11, 2012 |
376 |
| Svelte Medical Systems Announces Appointment of Jack Darby to President and Chief Executive Officer. |
|
|
Oct 10, 2012 |
798 |
| Lawsuits Against Stanford, Dr. Michael Dake for Experimental Procedures, Filed by San Francisco Firms Rouda Feder Tietjen & McGuinn and Emison Hullverson LLP. |
|
|
Oct 10, 2012 |
1510 |
| IDEV's Pivotal SUPERB Trial Demonstrates SUPERA Stent Significantly Exceeds VIVA Criteria for One-Year Patency in Femoropopliteal Artery Disease. |
|
|
Oct 10, 2012 |
958 |
| IDEV Announces Positive Two-Year Clinical Outcomes from Long Term Registry of the SUPERA Stent in Femoropopliteal Artery Disease. |
|
|
Oct 10, 2012 |
718 |
| IDEV's Pivotal SUPERB Trial Demonstrates SUPERA Stent Significantly Exceeds VIVA Criteria for One-Year Patency in Femoropopliteal Artery Disease. |
|
|
Oct 10, 2012 |
959 |
| IDEV Announces Positive Two-Year Clinical Outcomes from Long Term Registry of the SUPERA Stent in Femoropopliteal Artery Disease. |
|
|
Oct 10, 2012 |
609 |
| Cardionovum[R] Poised for Rapid Commercialization of Its Drug-Coated Balloons (DCB) and Drug-Eluting Stents (DES) in 57 Countries Outside of U.S. |
|
|
Oct 9, 2012 |
549 |
| Cook Medical Launches Zilver Vena[TM] Venous Self-Expanding Stent in Canada. |
|
|
Oct 5, 2012 |
464 |
| Spontaneous fracture of indwelling polyurethane ureteral stents: A case series and review of literature. |
Chua, Michael E.; Morales, Marcelino L. |
Case study |
Oct 1, 2012 |
3885 |
| Endovascular caudal retraction of the cranial end of a misplaced Viatorr TIPS prior to liver transplantation. |
Ray, M. Jordan; Savage, Clare; Klintmalm, Goran B.; Rees, Chet R. |
Clinical report |
Oct 1, 2012 |
1778 |
| Amman Hospital conducts stent implantation. |
|
|
Oct 1, 2012 |
364 |
| Biosensors Extends Licensing Agreement with Terumo to Sell BioMatrix Technology Globally. |
|
|
Oct 1, 2012 |
817 |
| SUPERA Stent Approved for Private Reimbursement in Australia. |
|
|
Sep 28, 2012 |
640 |
| Results of InspireMD's MASTER Stent Trial Scheduled for Late Breaking Trials Session at TCT in Miami, FL Oct. 24. |
|
|
Sep 27, 2012 |
1260 |
| SUPERA Stent Approved for Private Reimbursement in Australia. |
|
|
Sep 27, 2012 |
629 |
| France,United States : STENTYS Launches New Stent-Delivery System to Facilitate Implantation in More Complex Vessel Anatomies. |
|
|
Sep 27, 2012 |
327 |
| Stent serving some laughs at lunch time; TheDailyPreview. |
|
|
Sep 27, 2012 |
181 |
| Peripheral Vascular Market in Brazil, Russia, India and China to Grow Robustly at over Eight Percent Per Year Through 2016. |
|
|
Sep 26, 2012 |
566 |
| STENTYS Launches New Stent-Delivery System to Facilitate Implantation in More Complex Vessel Anatomies. |
|
|
Sep 26, 2012 |
408 |
| InspireMD Announces CEO Transition as it Sets Commercialization Plan for Advanced Stent Technology. |
|
|
Sep 25, 2012 |
990 |
| Boston Scientific Launches Drug Eluting Stent Solution to Treat Severe Lesions Below the Knee. |
|
|
Sep 24, 2012 |
1090 |
| Cutting-edge surgeries conducted. |
|
|
Sep 15, 2012 |
230 |
| Germany : BIOTRONIK Launches Pulsar-35 Self-Expanding Stent and Passeo-14 PTA Balloon Catheter. |
|
Clinical report |
Sep 15, 2012 |
350 |
| InspireMD Reports 2012 Fiscal Year Results. |
|
Financial report |
Sep 12, 2012 |
2146 |
| Drug-eluting stents equal on thrombosis. |
Sullivan G., Michele |
|
Sep 1, 2012 |
952 |
| United States : Medtronic Launches Resolute Integrity Coronary Stent System in Japan. |
|
|
Aug 29, 2012 |
434 |
| New England Journal of Medicine Publishes FAME II Trial Results Revealing Better Patient Outcomes with FFR-Guided Cardiac Stenting. |
|
|
Aug 28, 2012 |
1370 |
| Elixir Medical Receives CE Mark Approval for the DESyne[R] BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating. |
|
|
Aug 28, 2012 |
619 |
| Germany,United States : Medtronic Study Confirms Long-Term Safety of Drug-Eluting Coronary Stents. |
|
Clinical report |
Aug 28, 2012 |
274 |
| U.S. Market for Gastro Intestinal Devices. |
|
|
Aug 22, 2012 |
1732 |
| Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent. |
|
|
Aug 20, 2012 |
1126 |
| Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent. |
|
|
Aug 20, 2012 |
1144 |
| Cook Medical's Ongoing Zilver[R] PTX[R] Trial Data Show Higher Freedom From Target Lesion Revascularization (TLR) Rates Compared to Angioplasty and Bare Metal Stenting After Three Years. |
|
Clinical report |
Aug 13, 2012 |
307 |
| Cardionovum[R] Expects to Launch Next-Generation Product: Drug-Eluting Coronary Stent System, "PROLIMUS Biograde". |
|
|
Aug 8, 2012 |
482 |
| Abbott's Omnilink Elite Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease. |
|
|
Aug 7, 2012 |
1485 |
| Harvard Clinical Research Institute Successfully Completes Randomization in the DAPT Study. |
|
Clinical report |
Aug 7, 2012 |
1063 |
| Abbott's Omnilink Elite Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease. |
|
|
Aug 7, 2012 |
1489 |
| FDA Clears First Robotic-Assisted System for Coronary Artery Disease Stent Procedures. |
|
|
Jul 25, 2012 |
1055 |
| AXIOS(TM) Stent and Delivery System CE Mark Approval Expanded to Include Biliary Tract Drainage. |
|
|
Jul 17, 2012 |
607 |
| Research and Markets: U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating - Executive Summary. |
|
|
Jul 16, 2012 |
266 |
| Arterial Remodeling Technologies ("ART") Reports First Human Use of Its Next-Generation Bioresorbable Stent. |
|
|
Jul 16, 2012 |
715 |
| Terumo Completes U.S. Patient Enrollment in the OSPREY Trial to Evaluate the MISAGO Self-expanding Stent. |
|
|
Jul 11, 2012 |
974 |
| FlexStent[R] Biliary Self-Expanding Stent System receives FDA 510(k) SE Clearance Further Extending Family of FSS Products. |
|
|
Jul 10, 2012 |
323 |
| FDA Clears Cook Medical's Evolution[R] Colonic Controlled-Release Stent. |
|
|
Jul 9, 2012 |
728 |
| Cardionovum[R] Begins In Vivo Testing of Its Paclitaxel-Coated RESTORE[R] Drug-Eluting Balloon (DEB), Designed to Increase Drug-in-Tissue Concentration. |
|
|
Jul 3, 2012 |
460 |
| New Medtronic stent selected by FDA for new accelerated review program. |
|
|
Jul 1, 2012 |
541 |
| FSS Announces CE Mark for its FlexStent[R] Iliac Self Expanding Stent System. |
|
|
Jun 28, 2012 |
484 |
| OrbusNeich's Genous(TM) Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement. |
|
|
Jun 21, 2012 |
979 |
| European Market for Gastrointestinal Endoscopy Devices to Grow Slowly to Value of $1 Billion by 2016. |
|
Industry overview |
Jun 19, 2012 |
620 |
| STENTYS Starts Clinical Trial to Broaden Portfolio with New Drug-Eluting Stent. |
|
|
Jun 14, 2012 |
697 |
| ResearchMoz: Global Bare Metal Stents Market and Medical Imaging Equipment Market 2011-2015 - Market Research Report. |
|
Industry overview |
Jun 11, 2012 |
1420 |
| Asher Holzer Retires as President of InspireMD. |
|
|
Jun 5, 2012 |
837 |
| Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element(TM) Plus Platinum Chromium Stent System. |
|
|
Jun 4, 2012 |
1133 |
| OrbusNeich's Combo Dual Therapy Stent Gets Good Outcomes. |
|
|
May 31, 2012 |
915 |
| One-Year EVOLVE Trial Clinical Results Confirm Safety. |
|
|
May 31, 2012 |
1009 |
| Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012. |
|
Clinical report |
May 23, 2012 |
926 |
| Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD). |
|
|
May 21, 2012 |
421 |
| Promus Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in Platinum Small Vessel Study. |
|
|
May 21, 2012 |
1218 |
| PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study. |
|
|
May 18, 2012 |
1239 |
| Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS Stent Shown in Two Clinical Trial Subgroup Analyses. |
|
|
May 17, 2012 |
991 |
| Boston Scientific Announces FDA Approval and U.S. Launch of EPIC(TM) Vascular Stent. |
|
|
May 17, 2012 |
983 |
| Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries. |
|
|
May 16, 2012 |
1048 |
| STENTYS Self-Apposing[R] Stent shows very low mortality at one month in 1,000 high-risk heart attack patients. |
|
Clinical report |
May 16, 2012 |
736 |
| AXIOS(TM) Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis. |
|
|
May 15, 2012 |
700 |
| One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY(TM) Stent Versus PROMUS Element(TM) Platinum Chromium Stent. |
|
|
May 15, 2012 |
1602 |
| Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study. |
|
Clinical report |
May 15, 2012 |
654 |
| Arterial Remodeling Technologies ("ART") receives regulatory approval to begin First-In-Man "ARTDIVA" clinical trial with its next-generation bioresorbable stent. |
|
|
May 15, 2012 |
592 |
| Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD[TM] Novolimus Eluting Coronary Stent with Biodegradable Polymer. |
|
|
May 15, 2012 |
710 |
| Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe. |
|
|
May 15, 2012 |
942 |
| Abbott's XIENCE PRIME(TM) and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy. |
|
|
May 15, 2012 |
921 |
| One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety and Effectiveness Data of the Boston Scientific SYNERGY(TM) Stent Versus Promus Element(TM) Platinum Chromium Stent. |
|
|
May 15, 2012 |
1585 |
| Abbott's XIENCE PRIME(TM) and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy. |
|
|
May 15, 2012 |
921 |
| Boston Scientific Announces CE Mark and European Launch of Innova(TM) Self-expanding Bare-metal Stent System. |
|
|
May 14, 2012 |
1087 |
| International Stent Survey by iData Research Now Available at MarketPublishers.com. |
|
|
May 11, 2012 |
483 |
| Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of Real-World Peripheral Artery Disease Patients. |
|
|
May 10, 2012 |
702 |
| Tryton Announces Events at EuroPCR 2012. |
|
Clinical report |
May 9, 2012 |
846 |
| International Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012. |
|
|
May 9, 2012 |
953 |
| Medtronic Expands Availability of Valiant(R) Captivia(R) Stent Graft in Major Global Markets. |
|
|
May 8, 2012 |
813 |
| Abbott Gets Japan's Approval for XIENCE PRIME Stent. |
|
|
May 1, 2012 |
973 |
| NeuroSigma Awarded NIH Grant For Neurovascular Stent. |
|
|
May 1, 2012 |
597 |
| Saving a million hearts. |
Chappell, L. Terry |
Report |
May 1, 2012 |
3796 |
| U.S. Market for Gastrointestinal Endoscopic Devices 2012. |
|
|
Apr 23, 2012 |
2625 |
| Research and Markets: Global Stent Grafts Market 2011-2015 - The Global Stent Grafts Market to Grow At A CAGR Of 6.7 Percent over the Period 2011-2015. |
|
|
Apr 19, 2012 |
409 |
| Research and Markets: Drug-eluting Stent Market in China 2011-2015 Report Discusses That a Major Challenge in the DES Market in China Is the Fall in The Prices Of DES's. |
|
|
Apr 18, 2012 |
341 |
| Medtronic Announces Global Drug-Eluting Balloon Study. |
|
Clinical report |
Apr 17, 2012 |
814 |
| Medtronic Endurant[R] AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study. |
|
Clinical report |
Apr 16, 2012 |
514 |
| Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study. |
|
|
Apr 13, 2012 |
964 |
| NeuroSigma Awarded NIH Grant for Further Development of Its Thin-Film Nitinol Covered Neurovascular Stent. |
|
|
Apr 9, 2012 |
761 |
| Abbott Receives Approval for Next-Generation XIENCE PRIME[TM] Drug Eluting Stent in Japan. |
|
Company overview |
Apr 9, 2012 |
1308 |
| Drug-eluting Stent Market in China 2011-2015. |
|
|
Apr 4, 2012 |
639 |
| Arterial Remodeling Technologies ("ART") reports $2.9 million cash infusion to prepare its next-generation bioresorbable stent for First-in-Human study. |
|
|
Apr 4, 2012 |
591 |
| Totally bioresorbable composites prepared from poly(L-lactide)-co-(trimethylene carbonate) copolymers and Poly(L-lactide)-co-(glycolide) fibers as cardiovascular stent material. |
Han, Yam; Jin, Xiaoyun; Yang, Jian; Fan, Zhongyong; Lu, Zhiqian; Zhang, Yong; Li, Suming |
Report |
Apr 1, 2012 |
6513 |
| Colonic stent and percutaneous ethanol injection as a treatment for colocutaneous fistula secondary to benign stricture. |
Qandeel, H.; Abudeeb, H.; Hammad, A.; Murch, C.; Mukherjee, A. |
Case study |
Apr 1, 2012 |
755 |
| Consumer group battling approval of brain stent. |
|
|
Apr 1, 2012 |
800 |
| Electro and Magneto-Electropolished surface micropatterning on binary and Ternary Nitinol. |
Persaud, Dharam; Munroe, Norman; McGoron, Anthony |
Report |
Apr 1, 2012 |
6630 |
| In vitro evaluation of cytocompatibility of shellac as coating for intravascular devices. |
Peters, Kirsten; Prinz, Cornelia; Salamon, Achim; Rychly, Joachim; Neumann, Hans-Georg |
Report |
Apr 1, 2012 |
1739 |
| Data Presented at ACC.12 Demonstrate that OrbusNeich's Genous[TM] Stent Is Feasible and Safe in STEMI Patients. |
|
|
Mar 27, 2012 |
938 |
| Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients. |
|
Clinical report |
Mar 26, 2012 |
1226 |
| STENTYS Self-Apposing[TM] technology supported by breaking new scientific evidence. |
|
|
Mar 26, 2012 |
547 |
| Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium Stents. |
|
|
Mar 25, 2012 |
1407 |
| Landmark Analysis of Year Two Data From PLATINUM Workhorse Trial Demonstrates Superior Efficacy of PROMUS Element[TM] Platinum Chromium Stent Compared to PROMUS[R] (Xience V[R]) Stent. |
|
|
Mar 25, 2012 |
1433 |
| Global Markets for Coronary Stent Devices. |
|
|
Mar 22, 2012 |
3761 |
| Boston Scientific Begins U.S. and International Launch of WallFlex[R] Biliary Transhepatic Stent System. |
|
|
Mar 22, 2012 |
1252 |
| OrbusNeich's Genous[TM] Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity. |
|
|
Mar 22, 2012 |
746 |
| Research and Markets: Drug-eluting Stent Market in Japan 2011-2015 Report Discusses Various Challenges Impacting The Growth Of This Market Including The Presence Of Alternative Coronary Stents. |
|
|
Mar 22, 2012 |
367 |
| Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element[TM] Stent. |
|
|
Mar 20, 2012 |
1142 |
| Global Product Launch of Blue Medical's CE Approved Drug Eluting Balloon Protege and Stent on Drug Eluting Balloon Pioneer. |
|
|
Mar 20, 2012 |
462 |
| Global Product Launch of Blue Medical's CE Approved Drug Eluting Balloon Protege and Stent on Drug Eluting Balloon Pioneer. |
|
|
Mar 20, 2012 |
457 |
| PCI + stent no better than medical therapy for stable CAD. |
Moon, Mary Ann |
Clinical report |
Mar 15, 2012 |
508 |
| Stanford Hospital First in Northern California to Have Success-doubling Stroke Care Stent. |
|
|
Mar 12, 2012 |
672 |
| ICON Interventional Systems Receives CE Mark for the Nuloy[R] Coronary Stent System. |
|
|
Mar 8, 2012 |
395 |
| Abbott's Absolute Pro[R] Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease. |
|
|
Mar 7, 2012 |
1167 |
| Covidien Peripheral Vascular Stent System Receives FDA Approval. |
|
|
Mar 7, 2012 |
612 |
| InspireMD Announces its 2011 Year End Financial Results. |
|
Financial report |
Mar 6, 2012 |
4041 |
| Boston Scientific Announces Launch of PROMUS Element[TM] Platinum Chromium Stent System in Japan. |
|
|
Mar 1, 2012 |
1219 |
| SurModics' Hydrophilic Coating on Medtronic's Resolute Integrity[TM] Drug-Eluting Stent Delivery System. |
|
|
Mar 1, 2012 |
320 |
| Cook Medical Receives Japanese Approval to Market Its Zilver[R] PTX[R] Drug-Eluting Stent. |
|
|
Mar 1, 2012 |
465 |
| Boston Scientific stents get FDA nod for heart attack patients. |
|
|
Mar 1, 2012 |
327 |
| Boston Scientific Stents approved for myocardial infarction. |
|
|
Mar 1, 2012 |
491 |
| Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients. |
|
|
Feb 22, 2012 |
1082 |
| Medtronic Resolute Integrity Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease. |
|
|
Feb 17, 2012 |
1297 |
| The effective physician: the role of CABG. |
|
|
Feb 15, 2012 |
537 |
| MEDCAC grapples with stroke prevention. |
Wachter, Kerri |
|
Feb 15, 2012 |
1600 |
| 4000th Patient Treated With Innovative Tryton Side Branch Stent. |
|
|
Feb 15, 2012 |
831 |
| ResearchMoz: Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016). |
|
|
Feb 8, 2012 |
1457 |
| ResearchMoz: Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016). |
|
|
Feb 8, 2012 |
1461 |
| QualiMed "Biodegradable Stent Technology Platform" to be Used for "BIOMAGSCAR". |
|
|
Feb 7, 2012 |
1019 |
| Boston Scientific WallFlex[R] Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries. |
|
|
Feb 7, 2012 |
1427 |
| InspireMD Announces Positive Clinical Data From Trial of MGuard[TM]. |
|
Clinical report |
Feb 6, 2012 |
1359 |
| Boston Scientific Announces First Implant and Market Launch of PROMUS Element[TM] Plus Stent System in Europe. |
|
|
Feb 1, 2012 |
1285 |
| Stents and Surgery For Blocked Neck Arteries are Neck-and-Neck as Lasting Stroke Prevention. |
|
|
Feb 1, 2012 |
987 |
| Boston Scientific Announces First Implant and Market Launch of Promus Element[TM] Plus Stent System in Europe. |
|
|
Feb 1, 2012 |
990 |
| Boston Scientific Epic Stent Gets Positive Outcomes. |
|
|
Feb 1, 2012 |
715 |
| Aorto-conduit fistula developing four years after esophagectomy. |
Strong, S.; Higgs, S.; Streets, C.; Titcomb, D.; Barham, P.; Blazeby, J.; Hollowood, A. |
Case study |
Feb 1, 2012 |
983 |
| Fistula after pyloroplasty--a novel approach to the management of a leak following oesophagectomy. |
Richardson, J.; Richardson, M.; Nijjar, R. |
Case study |
Feb 1, 2012 |
945 |
| InspireMD Provides Corporate Update, Plans for 2012. |
|
|
Jan 23, 2012 |
1837 |
| European Coronary Stent Market to Decline to $490 Million by 2016, Despite Growth in Number of Procedures. |
|
Industry overview |
Jan 19, 2012 |
576 |
| Research and Markets: Innovations in Transcatheter Stents and Transcatheter Aortic Valves: examining devices, techniques and regulatory status. |
|
|
Jan 18, 2012 |
412 |
| Medtronic Endurant[R] II AAA Stent Graft System Launches Internationally with CE Mark. |
|
|
Jan 17, 2012 |
693 |
| Scripps-led Study in JAMA Shows New Drug Helps "Bridge" Stent Patients to Cardiac Surgery. |
|
|
Jan 17, 2012 |
923 |
| Boston Scientific Epic[TM] Stent Demonstrates Positive Clinical Outcomes in Orion Trial. |
|
|
Jan 16, 2012 |
1477 |
| OrbusNeich's Genous[TM] Stent Achieves Good, Comparable Clinical Outcomes in Patients Discontinuing Dual Antiplatelet Therapy at 30 Days and at Six Months. |
|
|
Jan 5, 2012 |
815 |
